大理药业
(603963)
| 流通市值：17.80亿 | | | 总市值：17.80亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 15,320,299.73 | 87,269,974.24 | 73,273,235.69 | 59,570,461.43 |
| 营业收入 | 15,320,299.73 | 87,269,974.24 | 73,273,235.69 | 59,570,461.43 |
| 二、营业总成本 | 21,992,916.15 | 113,265,711.49 | 90,850,259.08 | 71,195,102.42 |
| 营业成本 | 13,532,348.89 | 50,973,109.15 | 37,958,713.39 | 29,186,398.56 |
| 税金及附加 | 615,910.31 | 3,211,543.17 | 2,375,316.99 | 1,742,793.71 |
| 销售费用 | 3,216,092.49 | 39,776,408.73 | 36,453,506.25 | 30,325,004.46 |
| 管理费用 | 3,683,023.78 | 16,858,333.66 | 12,129,815.18 | 8,427,363.39 |
| 研发费用 | 699,464.63 | 839,523.58 | 662,555.38 | 583,576.33 |
| 财务费用 | 246,076.05 | 1,606,793.2 | 1,270,351.89 | 929,965.97 |
| 其中:利息费用 | 269,292.2 | 1,708,696.9 | 1,365,538.83 | 1,000,288.32 |
| 其中:利息收入 | 25,702.48 | 117,681.66 | 107,990.82 | 79,905.47 |
| 加:公允价值变动收益 | 854,416.68 | 4,678,557.28 | 3,582,935.08 | 2,502,717.47 |
| 加:投资收益 | 115,797.78 | 514,664.99 | 424,726.06 | 322,167.26 |
| 资产处置收益 | - | 52,463.03 | 52,463.03 | 52,463.03 |
| 资产减值损失(新) | - | 3,597,272.56 | - | - |
| 信用减值损失(新) | -13,067.43 | -144,972.47 | 178,464.69 | 62,390.93 |
| 其他收益 | 52,990.27 | 262,502.9 | 138,724.02 | 60,724.03 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -5,662,479.12 | -17,035,248.96 | -13,199,710.51 | -8,624,178.27 |
| 加:营业外收入 | 35,350.35 | 26,613.23 | 23,913.23 | 18,544.65 |
| 减:营业外支出 | 179.48 | 359,565.9 | 358,796.67 | 358,796.67 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -5,627,308.25 | -17,368,201.63 | -13,534,593.95 | -8,964,430.29 |
| 减:所得税费用 | -252,286.62 | 2,663,170.85 | 1,854,375.25 | 1,817,922.5 |
| 六、净利润 | -5,375,021.63 | -20,031,372.48 | -15,388,969.2 | -10,782,352.79 |
| 持续经营净利润 | -5,375,021.63 | -20,031,372.48 | -15,388,969.2 | -10,782,352.79 |
| 归属于母公司股东的净利润 | -5,375,021.63 | -20,031,372.48 | -15,388,969.2 | -10,782,352.79 |
| (一)基本每股收益 | -0.02 | -0.09 | -0.07 | -0.05 |
| (二)稀释每股收益 | -0.02 | -0.09 | -0.07 | -0.05 |
| 九、综合收益总额 | -5,375,021.63 | -20,031,372.48 | -15,388,969.2 | -10,782,352.79 |
| 归属于母公司股东的综合收益总额 | -5,375,021.63 | -20,031,372.48 | -15,388,969.2 | -10,782,352.79 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-27 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |